Singapore, 1 April 2025 – CDW Holding Limited, a SGX Mainboard-listed precision components specialist, announced today that its subsidiary ABio, in collaboration with Neoregen Biotech, is […]
Tag: Healthcare
Hyphens Pharma Secures Exclusive Rights to Commercialize Metoject® Auto-Injector in Southeast Asia
Singapore, 11 March 2025 – Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical group, has entered into an exclusive agreement with Germany’s medac GmbH to commercialize […]
Hyphens Pharma Reports Record FY2024 Results with 26.5% Net Profit Growth and 74% Dividend Increase
Singapore, 25 February 2025 – Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, today announced outstanding financial results for FY2024, achieving record […]
CDW Holding’s Subsidiary ABio Signs Joint R&D Agreement with Neoregen Biotech to Advance Next-Generation Lipid Nanoparticle Technology
Singapore, 20 January 2025 – CDW Holding Limited, a SGX Mainboard-listed precision components and life sciences specialist, today announced that its subsidiary, A Biotech, has signed […]
CDW Holding Announces Breakthroughs in Cancer-Targeting Antibody Research
Singapore, November 13, 2024 – CDW Holding Limited, a SGX Mainboard-listed company headquartered in Hong Kong, today announced significant progress in its biotechnology subsidiary’s antibody […]
Hyphens Pharma Reports Steady Growth in Q3 2024 with 22.1% Revenue Increase for Nine-Month Period
Singapore, 12 November 2024 – Hyphens Pharma Limited, a leading specialty pharmaceutical and consumer healthcare company, today announced its financial results for the third quarter and […]
Hyphens Pharma launches Ceradan® Advanced Hand Balm specially for hand eczema
Hyphens Pharma Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, launched its Ceradan® Advanced Hand Balm, the latest addition to its Ceradan® line for […]
Hyphens Pharma 1H2024 net profit jumps 66.7% to S$5.9 million
Hyphens Pharma Limited reported 1H2024 revenue grew by 33.4% to S$99.6 million in 1H2023 with all three business segments contributing to the growth. Revenue from […]
Hyphens Pharma to bring relief to Shingles sufferers in ASEAN with licensing of Amenalief®
Singapore’s leading specialty pharmaceutical and consumer healthcare group, Hyphens Pharma International Limited’s subsidiary, Hyphens Pharma Pte. Ltd., has entered into an exclusive license, development and […]
Hyphens Pharma 3Q2023 net profit drops to S$4 million due to challenging macro environment and record 3Q2022 results
Hyphens Pharma Limited has released its quarterly business update for 3Q2023 and 9M2023. 3Q2023 compared to 3Q2022 Revenue in 3Q2023 remained constant at S$42.8 million […]